When a cancer spreads to the bones, it’s called bone metastasis. It’s also called metastatic bone disease or secondary bone cancer, because the cancer didn’t start in the bones.
Bone metastasis may not be curable, but treatment may help people live longer and feel better.
The exact mechanism of how cancer cells metastasize to the bones isn’t fully known. It’s a very active area of scientific research. New understanding of how metastasis works is continuing to lead to new methods of treatment.
Bone is the
Cancer cells may metastasize to only one of your bones or to many at the same time. The most usual sites for bone metastases are your:
Types of bone metastases
Normally your bones are constantly changing. New bone tissue is being formed and old bone tissue is breaking down into minerals that circulate in your blood. This process is called remodeling.
Cancer cells upset the normal process of bone remodeling, causing bones to become weak or too dense, depending on the type of bone cells affected.
Your bone metastases may be:
- osteoblastic, if there are too many new bone cells (this often happens with metastasized prostate cancer)
- osteolytic, if too much bone is destroyed (this often happens with metastasized breast cancer)
In some cases, your bones may have both types of metastases.
The research on cancer metastasis is rapidly growing. As researchers better understand the mechanisms of bone metastasis, new drugs and other treatments are being developed. These target particular processes in cells involved in how the cancer cells invade and grow in bones.
The use of nanoparticles (billionths of a meter in size) to deliver drugs is very encouraging. These tiny particles are able to deliver drugs to the bone with minimal toxicity to the person with cancer.
Rapidly treating bone metastasis can lead to a
Survival rates for people with bone metastases vary greatly by cancer type and stage. Your general health condition and the type of treatment you received for the primary cancer are additional factors.
Discuss your particular situation with your doctor. Remember that survival rates are averages gathered from large numbers of people. Also, survival data may reflect statistics from a period before the most recent treatment advances.
A large-scale 2017 study of the 10 most common cancers with bone metastasis found:
- Lung cancer had the lowest 1-year survival rate after bone metastasis (10 percent).
- Breast cancer had the highest 1-year survival rate after bone metastasis (51 percent).
- Having metastases in bone and also in other sites was found to decrease the survival rate.
Here are some typical figures from a 2018 study of common cancers and bone metastasis:
|Type of cancer||Percent of cases that metastasize after 5 years||5-year survival rate after metastasis|
Each person’s treatment for bone metastases is individualized and requires a multidisciplinary approach. Your treatment plan will depend on:
- the type of primary cancer you have
- the stage of your cancer
- which bones are involved
- prior cancer treatments
- your overall health
You’re likely to have a combination of therapies that may include:
- radiation to slow metastasis growth and reduce pain
- chemotherapy to kill cancer cells and reduce tumor size
- hormone therapy to reduce the hormones known to be involved with breast and prostate cancer
- painkillers and steroids for pain relief
- drugs that specifically target bones
- surgery if necessary to stabilize your bone, fix a break, and help with pain
- physical therapy to strengthen your muscles and help you with mobility
- extreme heat or cold that targets cancer cells and may relieve pain
Specific drugs that target bones are an important part of therapy and a developing research area.
It’s important to begin bone-targeting treatment as soon as possible, and not wait until you have a fracture or other bone injury. A breast cancer study reported a lower risk of bone complications for people who started treatment
Bone-targeting drugs currently used include:
- denosumab, a human antibody that’s effective in preventing bone loss and bone deterioration
- bisphosphonates, bone-building drugs similar to those used in osteoporosis; these strengthen bones and reduce the pain of metastases
- trastuzumab (Herceptin), which targets particular breast cancer cells
- bortezomib, which inhibits the proteasomes that break down proteins; it’s approved for treating multiple myeloma and under study for other cancers
- radioactive elements (radiopharmaceuticals), which are injected into a vein and find and kill cancer cells in the bones
As we learn more about the mechanisms of how cancer cells invade and disrupt bones, scientists develop
Note that most cancer treatments have side effects. Discuss these with your doctors and evaluate the benefits versus risks for your treatment.
Ask your doctors about new developments in the field that may help you. Drug development for cancer is a fast-moving research area. The medical literature has articles on new possibilities under development and testing.
For example, the use of nanoparticles has the promise of enhancing both current drugs and new drugs under development. Nanoparticles can be used to deliver drugs to the metastasis site with fewer side effects.
You may be eligible for a
The National Cancer Institute has a
You can also check on bone metastases clinical trials at CenterWatch, a free listing service. You can sign up to be notified when a clinical trial matches what you’re looking for.
An estimated 330,000 people are living with bone metastases in the United States.
Talking with other people who are going through the same treatment (or pain) that you are can help. You may learn new ideas for coping, and you may be able to help others.
Caretakers of people with bone metastases may also benefit from a support group.